pmc logo image
Logo of cdliClin Vaccine Immunol SubscriptionsClin Vaccine Immunol Archive

Formats:

Clin Diagn Lab Immunol. 1997 May; 4(3): 328–333.
PMCID: PMC170527
Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.
T Jouault, C Delaunoy, B Sendid, F Ajana, and D Poulain
Unité INSERM 42, Domaine du CERTIA, Villeneuve d'Ascq, France.
Abstract
Candida albicans mannan is the major cell wall antigen that elicits antibodies considered to be of little diagnostic value. It comprises epitopes corresponding to sequences of alpha- and beta-1,2-linked mannose residues. Both types of oligomannosidic epitopes may also be present on the glycosidic portions of other C. albicans molecules, i.e., mannoproteins (MP) (either structural or enzymatic) and glycolipids. The human humoral responses against beta-1,2- and alpha-linked oligomannosides were investigated by C. albicans Western blotting by considering the elective distribution of beta-1,2-oligomannosidic epitopes over a 14- to 18-kDa phospholipomannan (PLM) and the presence of alpha-mannosidic epitopes over heavily glycosylated MP. Western blotting of 51 control sera confirmed the presence of antibodies against C. albicans as a commensal member of the indigenous microflora; an immunoglobulin G (IgG) reactivity linked to enzyme-linked immunosorbent assay mannan signals was found for both PLM (beta-1,2-Man residues) and MP (alpha-Man residues). Despite strong reactivities against mannan and MP, IgG from 21 hospitalized patients with mycological evidence of deep-tissue invasion by C. albicans very significantly failed to react or reacted only faintly with PLM. This downregulation of anti-beta-1,2-oligomannosidic epitopes, associated with tissue invasion by C. albicans, was confirmed in 3 of 4 AIDS patients with extended oroesophageal candidosis. The application of a dissociation procedure proved that the absence of PLM reactivity was not due to the presence of immune complexes. These data provide the first evidence for a qualitative modification of the human antimannan antibody response associated with the C. albicans commensal-pathogenic transition.
Full Text
The Full Text of this article is available as a PDF (879K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993 May;167(5):1247–1251. [PubMed]
  • Bodey GP, Anaissie EJ, Elting LS, Estey E, O'Brien S, Kantarjian H. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B. Cancer. 1994 Apr 15;73(8):2099–2106. [PubMed]
  • Bougnoux ME, Hill C, Moissenet D, Feuilhade de Chauvin M, Bonnay M, Vicens-Sprauel I, Pietri F, McNeil M, Kaufman L, Dupouy-Camet J, et al. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol. 1990 May;28(5):905–909. [PubMed]
  • Cantelli C, Trinel PA, Bernigaud A, Jouault T, Polonelli L, Poulain D. Mapping of beta-1,2-linked oligomannosidic epitopes among glycoconjugates of Candida species. Microbiology. 1995 Oct;141 (:2693–2697. [PubMed]
  • Casadevall A. Antibody immunity and invasive fungal infections. Infect Immun. 1995 Nov;63(11):4211–4218. [PubMed]
  • Case CP, MacGowan AP, Brown NM, Reeves DS, Whitehead P, Felmingham D. Prophylactic oral fluconazole and candida fungaemia. Lancet. 1991 Mar 30;337(8744):790. [PubMed]
  • Cassone A, Boccanera M, Adriani D, Santoni G, De Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun. 1995 Jul;63(7):2619–2624. [PubMed]
  • Castro M, Ralston NV, Morgenthaler TI, Rohrbach MS, Limper AH. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect Immun. 1994 Aug;62(8):3138–3145. [PubMed]
  • Chew WH, Theus TL. Candida precipitins. J Immunol. 1967 Feb;98(2):220–224. [PubMed]
  • Crampin AC, Matthews RC. Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. J Med Microbiol. 1993 Sep;39(3):233–238. [PubMed]
  • Domer JE. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit Rev Microbiol. 1989;17(1):33–51. [PubMed]
  • Dupont B, Graybill JR, Armstrong D, Laroche R, Touzé JE, Wheat LJ. Fungal infections in AIDS patients. J Med Vet Mycol. 1992;30 Suppl 1:19–28. [PubMed]
  • Edwards JE., Jr Invasive candida infections--evolution of a fungal pathogen. N Engl J Med. 1991 Apr 11;324(15):1060–1062. [PubMed]
  • Faille C, Michalski JC, Strecker G, Mackenzie DW, Camus D, Poulain D. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall. Infect Immun. 1990 Nov;58(11):3537–3544. [PubMed]
  • Faille C, Wieruszeski JM, Lepage G, Michalski JC, Poulain D, Strecker G. 1H-NMR spectroscopy of manno-oligosaccharides of the beta-1,2-linked series released from the phosphopeptidomannan of Candida albicans VW-32 (serotype A). Biochem Biophys Res Commun. 1991 Dec 31;181(3):1251–1258. [PubMed]
  • Fukazawa Y. Antigenic structure of Candida albicans. Immunochemical basis of the serologic specificity of the mannans in yeasts. Immunol Ser. 1989;47:37–62. [PubMed]
  • Garner RE, Rubanowice K, Sawyer RT, Hudson JA. Secretion of TNF-alpha by alveolar macrophages in response to Candida albicans mannan. J Leukoc Biol. 1994 Feb;55(2):161–168. [PubMed]
  • Guiot HF, Fibbe WE, van 't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis. 1994 Apr;18(4):525–532. [PubMed]
  • Han Y, Cutler JE. Antibody response that protects against disseminated candidiasis. Infect Immun. 1995 Jul;63(7):2714–2719. [PubMed]
  • Hernando FL, Cailliez JC, Trinel PA, Faille C, Mackenzie DW, Poulain D. Qualitative and quantitative differences in recognition patterns of Candida albicans protein and polysaccharide antigens by human sera. J Med Vet Mycol. 1993;31(3):219–226. [PubMed]
  • Iwama A, Yoshida M, Miwa A, Obayashi T, Sakamoto S, Miura Y. Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol. 1993 Sep;51(3):156–160. [PubMed]
  • Jouault T, Bernigaud A, Lepage G, Trinel PA, Poulain D. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages. Immunology. 1994 Oct;83(2):268–273. [PubMed]
  • Jouault T, Lepage G, Bernigaud A, Trinel PA, Fradin C, Wieruszeski JM, Strecker G, Poulain D. Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect Immun. 1995 Jun;63(6):2378–2381. [PubMed]
  • Li RK, Cutler JE. Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem. 1993 Aug 25;268(24):18293–18299. [PubMed]
  • Matthews R, Burnie J. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen. J Clin Microbiol. 1988 Mar;26(3):459–463. [PubMed]
  • Matthews R, Burnie JP, Lee W. The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Methods. 1991 Sep 20;143(1):73–79. [PubMed]
  • Matthews RC, Burnie JP, Tabaqchali S. Immunoblot analysis of the serological response in systemic candidosis. Lancet. 1984 Dec 22;2(8417-8418):1415–1418. [PubMed]
  • Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, Ricci P, Carotenuto M, Liso V, Nosari AM, Barbui T, Fasola G, Mandelli F. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med. 1994 Jun 1;120(11):913–918. [PubMed]
  • Mitsutake K, Kohno S, Miyazaki T, Miyazaki H, Maesaki S, Koga H. Detection of Candida enolase antibody in patients with candidiasis. J Clin Lab Anal. 1994;8(4):207–210. [PubMed]
  • Miyakawa Y, Kagaya K, Fukazawa Y, Soe G. Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans. J Clin Microbiol. 1986 May;23(5):881–886. [PubMed]
  • Nakamura A, Ishikawa N, Suzuki H. Diagnosis of invasive candidiasis by detection of mannan antigen by using the avidin-biotin enzyme immunoassay. J Clin Microbiol. 1991 Nov;29(11):2363–2367. [PubMed]
  • Nelson RD, Shibata N, Podzorski RP, Herron MJ. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin Microbiol Rev. 1991 Jan;4(1):1–19. [PubMed]
  • Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, et al. Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995 Jan 7;345(8941):17–20. [PubMed]
  • Odds FC, Evans EG. Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients. J Clin Pathol. 1980 Aug;33(8):750–756. [PubMed]
  • Poulain D, Faille C, Delaunoy C, Jacquinot PM, Trinel PA, Camus D. Probable presence of beta(1-2)-linked oligomannosides that act as human immunoglobulin G3 epitopes and are distributed over a Candida albicans 14- to 18-kilodalton antigen. Infect Immun. 1993 Mar;61(3):1164–1166. [PubMed]
  • Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev. 1993 Oct;6(4):311–323. [PubMed]
  • San-Blas G, Suzuki S, Hearn V, Pinel C, Kobayashi H, Mendez C, Niño G, Nishikawa A, San-Blas F, Shibata N, et al. Fungal polysaccharides. J Med Vet Mycol. 1994;32 Suppl 1:321–328. [PubMed]
  • Shibata N, Arai M, Haga E, Kikuchi T, Najima M, Satoh T, Kobayashi H, Suzuki S. Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues. Infect Immun. 1992 Oct;60(10):4100–4110. [PubMed]
  • Shibata N, Hisamichi K, Kobayashi H, Suzuki S. Complete assignment of 1H and 13C nuclear magnetic resonance chemical shifts of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Arch Biochem Biophys. 1993 Apr;302(1):113–117. [PubMed]
  • Sternberg S. The emerging fungal threat. Science. 1994 Dec 9;266(5191):1632–1634. [PubMed]
  • Switchenko AC, Miyada CG, Goodman TC, Walsh TJ, Wong B, Becker MJ, Ullman EF. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J Clin Microbiol. 1994 Jan;32(1):92–97. [PubMed]
  • Tojo M, Shibata N, Kobayashi M, Mikami T, Suzuki M, Suzuki S. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin Chem. 1988 Mar;34(3):539–543. [PubMed]
  • Trinel PA, Borg-von-Zepelin M, Lepage G, Jouault T, Mackenzie D, Poulain D. Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides. Infect Immun. 1993 Oct;61(10):4398–4405. [PubMed]
  • Trinel PA, Faille C, Jacquinot PM, Cailliez JC, Poulain D. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies. Infect Immun. 1992 Sep;60(9):3845–3851. [PubMed]
  • van Deventer AJ, van Vliet HJ, Hop WC, Goessens WH. Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol. 1994 Jan;32(1):17–23. [PubMed]
  • Walsh TJ, Hathorn JW, Sobel JD, Merz WG, Sanchez V, Maret SM, Buckley HR, Pfaller MA, Schaufele R, Sliva C, et al. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med. 1991 Apr 11;324(15):1026–1031. [PubMed]
  • Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989 Oct;149(10):2349–2353. [PubMed]